Consensus on the appropriate use of intrathecal baclofen (ITB) therapy in paediatric spasticity

Bernard Dan1, Francesco Motta, Johann S H Vles

  • 1Department of Neurology, Hôpital Universitaire des Enfants Reine Fabiola, Université libre de Bruxelles, 15 Avenue JJ Crocq, 1020 Brussels, Belgium. bernard.dan@ulb.ac.be

Insights

Intrathecal baclofen (ITB) offers a targeted treatment for childhood spasticity. This consensus statement guides clinicians on its use, emphasizing evidence-based practices and the need for more research.

Area of Science:

  • Pediatric Neurology
  • Rehabilitation Medicine

Background:

  • Spasticity in children significantly impacts morbidity and care, especially in severe cases.
  • Intrathecal baclofen (ITB) is an increasingly utilized, specific treatment for spasticity.
  • Existing evidence for pediatric ITB primarily stems from retrospective/uncontrolled studies.

Purpose of the Study:

  • To provide a consensus statement on the use of ITB in pediatric spasticity.
  • To offer guidance for clinicians based on current evidence.
  • To promote expert opinion and consistent management approaches.

Main Methods:

  • Development of a consensus statement based on available evidence.
  • Review of existing literature, including recent randomized controlled trials.
  • Expert opinion synthesis for clinical practice guidelines.

Main Results:

  • Recent randomized controlled trials provide new evidence for ITB screening and therapy.
  • The consensus aims to standardize the approach to ITB in pediatric patients.
  • Highlights the need for further large-scale, prospective studies.

Conclusions:

  • ITB is a valuable treatment option for pediatric spasticity.
  • A consistent, evidence-based approach is crucial for optimal patient outcomes.
  • Further research is essential to expand the evidence base for pediatric ITB.

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...